BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2004

View Archived Issues

Synta Pharmaceuticals gives update on clinical status of its products

Read More

Cambridge Antibody Technology and Lonza extend manufacturing agreement

Read More

Sicor stockholders approve merger

Read More

Azelaic acid found more effective than metronidazole in moderate papulopustular rosacea

Read More

Analgesic effects of gabapentin in patients with chronic daily headache

Read More

Novel EP4 agonists with potential utility in female infertility, asthma, etc.

Read More

Lilly presents new GLP-1 analogues in a recent patent

Read More

New TPO mimetics in early development at GSK

Read More

Two novel series of NF-kappaB activation inhibitors patented by GSK

Read More

Tanabe Seiyaku scientists claim new inhibitors of alpha4 integrin-mediated cell adhesion

Read More

Takeda scientists describe new GRK2 inhibitors for heart failure therapy

Read More

New CGRP antagonists identified by BMS researchers

Read More

SPP-301 shows good tolerability and pharmacokinetics in healthy subjects

Read More

CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines

Read More

Samaritan Pharmaceuticals reports drug development update

Read More

CPMP recommends use of Ambirix in children

Read More

FR-210575: a candidate for the treatment of stroke and other neurodegenerative disorders

Read More

CPMP recommends extension of Paxene indications

Read More

European approval recommended for Lysodren

Read More

EntreMed identifies peptide fragment of tissue factor pathway inhibitor

Read More

Successful pre-IND meeting for Itax leads to phase III studies

Read More

Velcade recommended for approval in Europe

Read More

FDA extends review of anidulafungin NDA

Read More

Syrrx reports DP4 atomic structure, selects DP4 inhibitor candidates

Read More

RegeneRx licenses out European rights to TB4

Read More

Kowa and Nikken enter olmesartan medoxmil copromotion agreement

Read More

Evra available in Canada

Read More

Lundbeck and Pharmexa enter option agreement

Read More

Profile Therapeutics makes good progress during last six months of 2003

Read More

Diabetic endothelial dysfunction in ZDF rats normalized with chronic AVE-7688 treatment

Read More

Inex and Enzon partner to develop Onco TCS

Read More

Axonyx acquires interest in Oxis International

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing